Closing Date
Thursday 10 April 2025
Reference
MED98625
Applications are invited from medically-qualified doctors who seek integrated academic and clinical training for a clinical academic career. One post is available in competition between applications from:
* Respiratory Medicine
* Endocrinology and Diabetes
* Renal Medicine
Interviews will be held on Friday 16th May.
The post will be offered on a fixed term contract for a period of up to 4 years (if full-time; up to a maximum of 6 years part-time, pro-rata) or until award of Certificate of Completion of Training (CCT), whichever is the shorter. Hours of work are full time or part time (minimum 0.6FTE). Successful applicants must be in post before 31 August 2025.
The successful candidate in this NIHR funded Clinical Lectureship will work with internationally acclaimed research groups in the University of Nottingham's School of Medicine, in which you will be trained in the latest state of the art techniques to improve health and well-being. You will be supported to develop an individual innovative and novel research programme leading to peer reviewed publications and research funding applications.
You must be GMC registered with a license to practice, already have a higher research degree (PhD or MD by research or equivalent) and fulfil all essential criteria on the appropriate person specification.
To accompany your application, you must complete and upload to the University's application system, the NIHR's supplementary questions available at this link.
Applications without the NIHR's supplementary questions from the link above cannot be considered.
Informal enquiries may be addressed to:
* Academic Programme Director (Respiratory Medicine) - Professor Charlotte Bolton charlotte.bolton@nottingham.ac.uk
* Academic Programme Director (Endocrinology and Diabetes) - Professor Iskandar Idris iskandar.idris@nottingham.ac.uk
* Academic Programme Director (Renal Medicine) - Professor Nick Selby nicholas.selby@nottingham.ac.uk
Please note that applications sent directly to these email addresses will not be accepted.
It is a condition of this post that satisfactory enhanced disclosure is obtained from the 'Disclosure and Barring Service'.
#J-18808-Ljbffr